人民币ETF-Wisdom Tree CYB 深 沪
等待开盘 10-02 09:30:00 美东时间
24.2674
0.000
0.00%
华盛通- 最 高--
- 今 开--
- 成交量 0股
- 最 低 --
- 昨 收 24.2674
- 总市值 2426.74万
- 52周最高 25.92
- 市盈率 静 --
- 换手率 0.00%
- 52周最低 23.4002
- 委 比 0.00%
- 总股本 100.00万
- 历史最高 27.0852
- 量 比 0
- 振 幅 0.00%
- 历史最低 4.5564
- 每 手 1
- 风险率 0.03%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多Cybin Highlights Neuropsychiatry Platform And Upcoming Clinical Milestones; Completes Enrollment Of 36 Participants In Phase 2 Study Of CYB004; Continues To Advance CYB003, The Company's Proprietary Deuterated Psilocin Analog, In Phase 3 Studies For The Adjunctive Treatment Of Major Depressive Disorder; Dosing Is Ongoing In The First Pivotal Study, APPROACH , With Expected Enrollment Of 220 Patients Across 45 U.S. Clinical Sites
- Successfully completed enrollment of 36 participants in Phase 2 study of CYB004, the Company's deuterated dimethyltryptamine ("DMT") program for the treatment of Generalized Anxiety Disorder ("GAD"). Topline data
09-24 05:16
Director’s Interest Change at AUCYBER LIMITED
An announcement from Sovereign Cloud Holdings Ltd. ( ($AU:CYB) ) is now availab...
09-04 16:47
5G Networks Increases Stake in AUCyber to Over 90%
The latest announcement is out from Sovereign Cloud Holdings Ltd. ( ($AU:CYB) )...
09-04 16:47
Cybin Names Co-Founder Eric So As Interim CEO As Doug Drysdale Steps Down
Cybin Inc. (NYSE:CYBN) (Cboe Canada:CYBN) ("Cybin" or the "Company"), a clinical-stage breakthrough neuropsychiatry company committed to revolutionizing mental healthcare by developing new and innovative next-generation
09-02 19:34
人民币汇率：为何加速升值？
本文来自格隆汇专栏：梁中华宏观研究 作者：韩朝辉、梁中华 概要 本轮汇率升值趋势首先由持汇者（跨境资本、外贸企业）推动，而内资相对谨慎（体现在...
09-02 09:12
Cyberoo Announces Share Buyback to Strengthen Market Position
Cyberoo S.p.A. ( ($IT:CYB) ) just unveiled an update. Cyberoo S.p.A. has announ...
08-15 03:05
AUCyber Limited Appoints New CFO to Drive Financial Growth
Sovereign Cloud Holdings Ltd. ( ($AU:CYB) ) just unveiled an update. AUCyber Li...
08-13 14:47
Cyberoo S.p.A. Announces Share Buyback on Euronext Growth Milan
Cyberoo S.p.A. ( ($IT:CYB) ) has provided an announcement. Cyberoo S.p.A. annou...
08-12 00:26
Cybin's Clinical Trial Application Approved By Irish Medicines Board To Initiate EMBRACE Study In Ireland, Poland, And Greece
- EMBRACE, the second study within the Phase 3 PARADIGM program, will enroll 330 participants at approximately 60 clinical sites across the United States, Europe, the United Kingdom, and Australia -- European CTA
08-07 19:42
Cyberoo S.p.A. Acquires 10,000 Own Shares to Bolster Market Position
Cyberoo S.p.A. ( ($IT:CYB) ) has provided an announcement. Cyberoo S.p.A. has a...
08-04 17:24
